EU-LIFE publishes its views in position papers ranging from policy statements to detailed analysis and concrete recommendations. They are disseminated to policy makers, media and other stakeholders in the research area.
The use of animals for the generation of high quality antibodies remains necessary for research and therapeutic applications
EU-LIFE launched a Policy Webinar Series this year with the aim to deepen the alliance contribution to key European policies and promote bridges...
Seven EU-LIFE members get together to launch a European-wide PhD program to train physician-scientists
CRG (Spain), Institut Curie (France), BRIC (Denmark), IGC (Portugal), MDC (Germany), NKI (The Netherlands), and VIB (Belgium), all members of the EU...
The Institute of Molecular Biology & Biotechnology (IMBB FORTH - Greece) becomes a full member of EU-LIFE
The Institute of Molecular Biology & Biotechnology (IMBB FORTH), a leading research institute in Greece, becomes EU-LIFE Full Member after joining the...